Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in the Czech Republic

Jun 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PRE-COVID-19 PERFORMANCE

Population ageing drives expansion of Rx/reimbursement adult incontinence in 2019

Rx/reimbursement adult incontinence continued to perform well in 2019, with volume and current value growth rates improving slightly from 2018. As was the case with retail adult incontinence, the positive development of the category was primarily due to population ageing in the Czech Republic.

2019 sees changes to legislation governing Rx/reimbursement adult incontinence

Incontinence products are considered medical devices under Czech law, and are subsidised by health insurance companies if prescribed by doctors (GPs, urologists, gynaecologists, geriatricians etc). There are monthly limits on the quantity and value of incontinence products for which individual users can be reimbursed.

Multinationals remain dominant in 2019

The same multinational companies that controlled the retail category continued to dominate Rx/reimbursement adult incontinence in 2019. Essity was the leading player with its Tena brand, while other top competitors included Hartmann-Rico with MoliCare, Kimberly-Clark with Depend, Ontex with iD Expert, Untraco with Abri and TZMO with Bella Control.

2020 AND BEYOND

COVID-19 impact

RX/reimbursement adult incontinence value sales at constant 2019 prices are expected to grow by 1% in 2020 in light of the impact of COVID-19.

Recovery and opportunities

RX/reimbursement adult incontinence looks set to perform well over the forecast period, with volume and current value growth rates expected to improve steadily towards 2024. The expansion of the category will continue to be underpinned by population ageing in the Czech Republic.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Czech Republic with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Czech Republic, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Czech Republic market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Czech Republic?
What are the major brands in Czech Republic?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in the Czech Republic - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Population ageing drives expansion of Rx/reimbursement adult incontinence in 2019

2019 sees changes to legislation governing Rx/reimbursement adult incontinence

Multinationals remain dominant in 2019

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

Tissue and Hygiene in the Czech Republic - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Consumers show growing preference for added-value products in 2019

Procter & Gamble leads in 2019 as private label continue to gain ground

Outlook remains reasonably favourable despite COVID-19 disruption

Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2017-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS

Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in the Czech Republic

New Report Guarantee

Executive Summary

New Report Guarantee

PRE-COVID-19 PERFORMANCE

Population ageing drives expansion of Rx/reimbursement adult incontinence in 2019

2019 sees changes to legislation governing Rx/reimbursement adult incontinence

Multinationals remain dominant in 2019

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in the Czech Republic - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Population ageing drives expansion of Rx/reimbursement adult incontinence in 2019

2019 sees changes to legislation governing Rx/reimbursement adult incontinence

Multinationals remain dominant in 2019

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Tissue and Hygiene in the Czech Republic - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Consumers show growing preference for added-value products in 2019

Procter & Gamble leads in 2019 as private label continue to gain ground

Outlook remains reasonably favourable despite COVID-19 disruption

MARKET INDICATORS

MARKET DATA

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports